Clinical Endocannabinoid Deficiency (CECD) as a Possible Explanation for the Benefits of Cannabis
Published in Neuro Endocrinology Letters -- This study examines the concept of clinical endocannabinoid deficiency (CECD), and the prospect that it could underlie the pathophysiology of migraine, fibromyalgia, irritable bowel syndrome, and other functional conditions alleviated by medicinal cannabis. Follow the link to read the full summary.
Syndicate content